Systematic identification of genetic loci required for polymyxin resistance in Campylobacter jejuni using an efficient in vivo transposon mutagenesis system

Foodborne Pathogens and Disease

Volumn 6, Issue 2, 2009, Pages 173-185

  Lin, Jun ^a   Wang, Ying ^a,b   Van Hoang, Ky ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOOLIGOSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; URIDINE DIPHOSPHATE GLUCOSE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CAMPYLOBACTER JEJUNI; DRUG SENSITIVITY; EVALUATION; GENE INSERTION; GENE LOCATION; HOST RESISTANCE; IN VIVO STUDY; INNATE IMMUNITY; MUTAGENESIS; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TRANSPOSON;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; POLYMYXINS; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER JEJUNI;

EID: 61349161639     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2008.0177     Document Type: Article

References (53)

1. Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, Xu W, Klevit RE, Le Moual H, and Miller SI. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 2005;122:461-472.
2. Black RE, Levine MM, Clements ML, Hughes TP, and Blaser MJ. Experimental Campylobacter jejuni infection in humans. J. Infect. Dis. 1988;157:472-479.
3. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005;3:238-250.
4. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, and Bengoechea JA. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 2004;72:7107-7114.
5. Chakrabarty AM. Nucleoside diphosphate kinase: role in bacterial growth, virulence, cell signalling and polysaccharide synthesis. Mol. Microbiol. 1998;28:875-882.
6. Chow CS, Lamichhane TN, and Mahto SK. Expanding the nucleotide repertoire of the ribosome with posttranscriptional modifications. ACS Chem. Biol. 2007;2:610-619.
7. Colegio OR, Griffin TJ, Grindley ND, and Galan JE. In vitro transposition system for efficient generation of random mutants of Campylobacter jejuni. J. Bacteriol. 2001;183:2384-2388.
8. Cosseau C and Batut J. Genomics of the ccoNOQP-encoded cbb3 oxidase complex in bacteria. Arch. Microbiol. 2004;181:89-96.
9. Cotter PD, Hill C, and Ross RP. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 2005;3:777-788.
10. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, and Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 2001;7:24-34.
11. Ernst RK, Guina T, and Miller SI. Salmonella Typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 2001;3:1327-1334.
12. Falagas ME and Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 2005;40:1333-1341.
13. Falagas ME and Michalopoulos A. Polymyxins: old antibiotics are back. Lancet 2006;367:633-634.
14. Finlay BB and Hancock RE. Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2004;2:497-504.
15. Friedman CR, Neimann J, Wegener HC, and Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Campylobacter. Nachamkin I and Blaser MJ (eds.). Washington, D.C.: ASM Press, 2000, pp. 121-138.
16. Golden NJ, Camilli A, and Acheson DW. Random transposon mutagenesis of Campylobacter jejuni. Infect. Immun. 2000;68:5450-5453.
17. Goryshin IY, Jendrisak J, Hoffman LM, Meis R, and Reznikoff WS. Insertional transposon mutagenesis by electroporation of released Tn5 transposition complexes. Nat. Biotechnol. 2000;18:97-100.
18. Goryshin IY and Reznikoff WS. Tn5 in vitro transposition. J. Biol. Chem. 1998;273:7367-7374.
19. Groisman EA. The pleiotropic two-component regulatory system PhoP-PhoQ. J. Bacteriol. 2001;183:1835-1842.
20. 2+ environments. J. Bacteriol. 1997;179:7040-7045.
21. Guerry P, Szymanski CM, Prendergast MM, Hickey TE, Ewing CP, Pattarini DL, and Moran AP. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect. Immun. 2002;70:787-793.
22. Hancock RE and Chapple DS. Peptide antibiotics. Antimicrob. Agents Chemother. 1999;43:1317-1323.
23. Hendrixson DR, Akerley BJ, and DiRita VJ. Transposon mutagenesis of Campylobacter jejuni identifies a bipartite energy taxis system required for motility. Mol. Microbiol. 2001;40:214-224.
24. Hensel M, Shea JE, Gleeson C, Jones MD, Dalton E, and Holden DW. Simultaneous identification of bacterial virulence genes by negative selection. Science 1995;269:400-403.
25. Hoffman LM, Jendrisak JJ, Meis RJ, Goryshin IY, and Reznikof SW. Transposome insertional mutagenesis and direct sequencing of microbial genomes. Genetica 2000;108:19-24.
26. Jorgensen JH and Turnidge JD. Susceptibility test methods: dilution and disk diffusion methods. In: Manual of Clinical Microbiology. Murray PR, Barton EJ, Jorgensen JH, Pfaller MA, and Yolken RH (eds.). Washington, D.C.: American Society for Microbiology, 2003, pp. 1109-1127.
27. Juretic D, Hendler RW, Kamp F, Caughey WS, Zasloff M, and Westerhoff HV. Magainin oligomers reversibly dissipate delta microH + in cytochrome oxidase liposomes. Biochemistry 1994;33:4562-4570.
28. Karlyshev AV, Ketley JM, and Wren BW. The Campylobacter jejuni glycome. FEMS Microbiol. Rev. 2005;29:377-390.
29. Kusano T, Izaki K, and Takahashi H. Degradation of phospholipid in Pseudomonas aeruginosa induced by polymyxin B. J. Antibiot. (Tokyo) 1975;28:689-695.
30. Lin J, Michel LO, and Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother 2002;46:2124-2131.
31. Line JE, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Svetoch OE, Seal BS, Siragusa GR, and Stern NJ. Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 2008;52:1094-1100.
32. McCoy AJ, Liu H, Falla TJ, and JS Gunn. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. Antimicrob. Agents Chemother. 2001;45:2030-2037.
33. Moll GN, Clark J, Chan WC, Bycroft BW, Roberts GC, Konings WN, and Driessen AJ. Role of transmembrane pH gradient and membrane binding in nisin pore formation. J. Bacteriol. 1997;179:135-140.
34. Nachamkin I, Allos BM, and Ho T. Campylobacter species and Guillain-Barre syndrome. Clin. Microbiol. Rev. 1998;11:555-567.
35. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, van Vliet AH, Whitehead S, and Barrell BG. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000;403:665-668.
36. Reid AN, Pandey R, Palyada K, Whitworth L, Doukhanine E, and Stintzi A. Identification of Campylobacter jejuni genes contributing to acid adaptation by transcriptional profiling and genome-wide mutagenesis. Appl. Environ. Microbiol. 2008;74:1598-1612.
37. Skirrow MB and Blaser MJ. Clinical aspects of Campylobacter infection. In: Campylobacter. Nachamkin I and Blaser MJ (eds.). Washington, D.C.: American Society for Microbiology, 2000, pp. 69-88.
38. Stern NJ, Svetoch EA, Eruslanov BV, Kovalev YN, Volodina LI, Perelygin VV, Mitsevich EV, Mitsevich IP, and Levchuk VP. Paenibacillus polymyxa purified bacteriocin to control Campylobacter jejuni in chickens. J. Food Prot. 2005;68:1450-1453.
39. Stern NJ, Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Pokhilenko VD, Levchuk VP, Svetoch OE, and Seal BS. Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob. Agents Chemother. 2006;50:3111-3116.
40. Svetoch EA, Eruslanov BV, Perelygin VV, Mitsevich EV, Mitsevich IP, Borzenkov VN, Levchuk VP, Svetoch OE, Kovalev YN, Stepanshin YG, Siragusa GR, Seal BS, and Stern NJ. Diverse antimicrobial killing by enterococcus faecium E 50-52 bacteriocin. J. Agric. Food Chem. 2008;56:1942-1948.
41. Tanaka N and Igusa S. Effects of viomycin and polymyxin B on protein synthesis in vitro. J. Antibiot. (Tokyo) 1968;21:239-240.
42. Teuber M. Precipitation of ribosomes from E. coli B by polymyxin B. Naturwissenschaften 1967;54:71.
43. Turcot I, Ponnampalam TV, Bouwman CW, and Martin NL. Isolation and characterization of a chromosomally encoded disulphide oxidoreductase from Salmonella enterica serovar Typhimurium. Can. J. Microbiol. 2001;47:711-721.
44. van Dijk A, Veldhuizen EJ, Kalkhove SI, Tjeerdsma-van Bokhoven JL, Romijn RA, and Haagsman HP. The beta-defensin gallinacin-6 is expressed in the chicken digestive tract and has antimicrobial activity against food-borne pathogens. Antimicrob. Agents Chemother. 2007;51:912-922.
45. van Vliet AHM, Wood AC, Henderson J, Wooldridge K, and Ketley JM. Genetic manipulation of enteric Campylobacter species. In: Bacterial Pathogenesis: Methods in Microbiology. Williams P, Ketley J, and Salmond G (eds.). London: Academic Press, 1998, pp. 407-419.
46. Wehkamp J, Schauber J, and Stange EF. Defensins and cathelicidins in gastrointestinal infections. Curr. Opin. Gastroenterol. 2007;23:32-38.
47. Weickert MJ and Adhya S. The galactose regulon of Escherichia coli. Mol. Microbiol. 1993;10:245-251.
48. Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, and Zhang G. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J. Biol. Chem. 2006;281:2858-2867.
49. Xiao Y, Hughes AL, Ando J, Matsuda Y, Cheng JF, Skinner-Noble D, and Zhang G. A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensins. BMC Genomics 2004;5:56.
50. Yao R, Alm RA, Trust TJ, and Guerry P. Construction of new Campylobacter cloning vectors and a new mutational cat cassette. Gene 1993;130:127-130.
51. Yeaman MR and Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003;55:27-55.
52. Zhang Q, Meitzler JC, Huang S, and Morishita T. Sequence polymorphism, predicted secondary structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane protein. Infect. Immun. 2000;68:5679-5689.
53. Zilbauer M, Dorrell N, Boughan PK, Harris A, Wren BW, Klein NJ, and Bajaj-Elliott M. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect. Immun. 2005;73:7281-7289.